Graphene and graphene oxide with anticancer applications: Challenges and future perspectives
Status PubMed-not-MEDLINE Language English Country China Media electronic-ecollection
Document type Journal Article, Review
PubMed
35281783
PubMed Central
PMC8906468
DOI
10.1002/mco2.118
PII: MCO2118
Knihovny.cz E-resources
- Keywords
- cancer nanotherapy, graphene, graphene oxide, graphene‐based nanomaterials,
- Publication type
- Journal Article MeSH
- Review MeSH
Graphene-based materials have shown immense pertinence for sensing/imaging, gene/drug delivery, cancer therapy/diagnosis, and tissue engineering/regenerative medicine. Indeed, the large surface area, ease of functionalization, high drug loading capacity, and reactive oxygen species induction potentials have rendered graphene- (G-) and graphene oxide (GO)-based (nano)structures promising candidates for cancer therapy applications. Various techniques namely liquid-phase exfoliation, Hummer's method, chemical vapor deposition, chemically reduced GO, mechanical cleavage of graphite, arc discharge of graphite, and thermal fusion have been deployed for the production of G-based materials. Additionally, important criteria such as biocompatibility, bio-toxicity, dispersibility, immunological compatibility, and inflammatory reactions of G-based structures need to be systematically assessed for additional clinical and biomedical appliances. Furthermore, surface properties (e.g., lateral dimension, charge, corona influence, surface structure, and oxygen content), concentration, detection strategies, and cell types are vital for anticancer activities of these structures. Notably, the efficient accumulation of anticancer drugs in tumor targets/tissues, controlled cellular uptake properties, tumor-targeted drug release behavior, and selective toxicity toward the cells are crucial criteria that need to be met for developing future anticancer G-based nanosystems. Herein, important challenges and future perspectives of cancer therapy using G- and GO-based nanosystems have been highlighted, and the recent advancements are deliberated.
Department of Chemistry Cape Breton University Sydney Canada
Faculty of Pharmacy and Pharmaceutical Sciences Isfahan University of Medical Sciences Isfahan Iran
See more in PubMed
Leong WS, Nai CT, Thong JT. What does annealing do to metal‐graphene contacts. Nano Lett. 2014;14(7):3840‐3847. PubMed
Lee C, Xiaoding W, Jeffrey WK, James H. Measurement of the elastic properties and intrinsic strength of monolayer graphene. Science. 2008;321(5887):385‐388. PubMed
Loh KP, Bao Q, Eda G, Chhowalla M. Graphene oxide as a chemically tunable platform for optical applications. Nat Chem. 2010;2(12):1015‐1024. PubMed
Bolotin K, Sikes K, Jiang Z, et al. Ultrahigh electron mobility in suspended graphene. Solid State Commun. 2008;146:351.
Sajibul M, Bhuyan A, Uddin MN, Islam MM, Bipasha FA, Hossain SS. Synthesis of graphene. Int Nano Lett. 2016;6(2):65.
Ali R, Hammad Aziz M, Gao S, et al. Graphene oxide/zinc ferrite nanocomposite loaded with doxorubicin as a potential theranostic mediu in cancer therapy and magnetic resonance imaging. Ceram Int. 2022. 10.1016/j.ceramint.2021.12.290 DOI
Zhu Y, Murali S, Cai W, et al. Graphene and graphene oxide: synthesis, properties, and applications. Adv Mater. 2010;22(25):3906‐3924. PubMed
Ramanathan T, Abdala A, Stankovich S, et al. Functionalized graphene sheets for polymer nanocomposites. Nat Nanotechnol. 2008;3(6):327‐331. PubMed
Wang K, Ruan J, Song H, et al. Biocompatibility of graphene oxide. Nanoscale Res Lett. 2011;6(1):1‐8. PubMed PMC
Dresselhaus MS, Dresselhaus G. Intercalation compounds of graphite. Adv Phys. 2002;51(1):1‐186.
Liu Z, Robinson JT, Sun X, Dai H. PEGylated nanographene oxide for delivery of water‐insoluble cancer drugs. J Am Chem Soc. 2008;130(33):10876‐10877. PubMed PMC
Novoselov KS, Geim AK, Morozov SV, et al. Electric field effect in atomically thin carbon films. Science. 2004;306(5696):666‐669. PubMed
Alemi F, Zarezadeh R, Sadigh AR, et al. Graphene oxide and reduced graphene oxide: efficient cargo platforms for cancer theranostics. J Drug Deliv Sci Technol. 2020;60:101974.
Karki N, Tiwari H, Tewari C, et al. Functionalized graphene oxide as a vehicle for targeted drug delivery and bioimaging applications. J Mater Chem B. 2020;8(36):8116‐8148. PubMed
Buskaran K, Hussein MZ, Mohd Moklas MA, Fakurazi S. Morphological changes and cellular uptake of functionalized graphene oxide loaded with protocatechuic acid and folic acid in hepatocellular carcinoma cancer cell. Int J Mol Sci. 2020;21(16):5874. PubMed PMC
Shafiee A, Aibaghi B, Carrier AJ, et al. Rapid photodegradation mechanism enabled by broad‐spectrum absorbing black anatase and reduced graphene oxide nanocomposites. Appl Surf Sci. 2022;575:151718.
Kuo W‐S, Chen H‐H, Chen S‐Y, et al. Graphene quantum dots with nitrogen‐doped content dependence for highly efficient dual‐modality photodynamic antimicrobial therapy and bioimaging. Biomaterials. 2017;120:185‐194. PubMed
Alegret N, Criado A, Prato M. Recent advances of graphene‐based hybrids with magnetic nanoparticles for biomedical applications. Curr Med Chem. 2017;24(5):529‐536. PubMed PMC
Masoudipour E, Kashanian S, Maleki N. A targeted drug delivery system based on dopamine functionalized nano graphene oxide. Chem Phys Lett. 2017;668:56‐63.
Pattnaik S, Swain K, Lin Z. Graphene and graphene‐based nanocomposites: biomedical applications and biosafety. J Mater Chem B. 2016;4(48):7813‐7831. PubMed
Rahdar A, Hajinezhad MR, Hamishekar H, Ghamkhari A, Kyzas GZ. Copolymer/graphene oxide nanocomposites as potential anticancer agents. Polym Bull. 2021;78:4877‐4898.
Hoseini‐Ghahfarokhi M, Mirkiani S, Mozaffari N, et al. Applications of graphene and graphene oxide in smart drug/gene delivery: is the world still flat. Int J Nanomed. 2020;15:9469‐9496. PubMed PMC
Varma RS, Len C. Glycerol valorization under continuous flow conditions‐recent advances. Curr Opin Green Sustain Chem. 2019;15:83‐90.
Wang Z, Huang P, Bhirde A, et al. A nanoscale graphene oxide–peptide biosensor for real‐time specific biomarker detection on the cell surface. ChemComm. 2012;48(78):9768‐9770. PubMed PMC
Guo C, Book‐Newell B, Irudayaraj J. Protein‐directed reduction of graphene oxide and intracellular imaging. ChemComm. 2011;47(47):12658‐12660. PubMed
Yang X, Wang Y, Huang X, et al. Multi‐functionalized graphene oxide based anticancer drug‐carrier with dual‐targeting function and pH‐sensitivity. J Mater Chem. 2011;21(10):3448‐3454.
Peng C, Hu W, Zhou Y, Fan C, Huang Q. Intracellular imaging with a graphene‐based fluorescent probe. Small. 2010;6(15):1686‐1692. PubMed
Sheng Z, Song L, Zheng J, et al. Protein‐Assisted fabrication of nano‐reduced graphene oxide for combined vivo photoacoustic imaging and photothermal therapy. Biomaterials. 2013;34(21):5236‐5243. PubMed
Yin PT, Shah S, Chhowalla M, Lee K‐B. Design, synthesis, and characterization of graphene‐nanoparticle hybrid materials for bioapplications. Chem Rev. 2015;115(7):2483‐2531. PubMed PMC
GhosalKishor K, Sarkar K. Biomedical applications of graphene nanomaterials and beyond. ACS Biomater Sci Eng. 2018;4:2653‐2703. PubMed
Sajjadi M, Nasrollahzadeh M, Jaleh B, Jamalipour Soufi G, Iravani S. Carbon‐based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects. J Drug Target. 2021;29(7):716‐741. PubMed
Lingaraju K, Naika HR, Nagaraju G, Nagabhushana H. Biocompatible synthesis of reduced graphene oxide from Euphorbia heterophylla (L.) and their in‐vitro cytotoxicity against human cancer cell lines. Biotechnol Rep. 2019;24:e00376. PubMed PMC
Gurunathan S, Han JW, Eppakayala V, Kim J‐H. Green synthesis of graphene and its cytotoxic effects in human breast cancer cells. Int J Nanomedicine. 2013;8:1015‐1027. PubMed PMC
Han X‐M, Zheng K‐W, Wang R‐L, et al. Functionalization and optimization‐strategy of graphene oxide‐based nanomaterials for gene and drug delivery. Am J Transl Res. 2020;12(5):1515‐1534. PubMed PMC
Nobile MR, Raimondo M, Naddeo C, Guadagno L. Rheological and morphological properties of non‐covalently functionalized graphene‐based structural epoxy resins with intrinsic electrical conductivity and thermal stability. Nanomaterials. 2020;10(7):1310. PubMed PMC
Neri G, Fazio E, Nostro A, et al. Shedding light on the chemistry and the properties of münchnone functionalized graphene. Nanomaterials. 2021;11(7):1629. PubMed PMC
Liu J, Cui L, Losic D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater. 2013;9(12):9243‐9257. PubMed
Chung C, Kim Y‐K, Shin D, Ryoo S‐R, Hong BH, Min D‐H. Biomedical applications of graphene and graphene oxide. Acc Chem Res. 2013;46:2211‐2224. PubMed
Nasrollahzadeh M, Sajjadi M, Iravani S, Varma RS. Trimetallic nanoparticles: greener synthesis and their applications. Nanomaterials. 2020;10(9):1784. PubMed PMC
Nasrollahzadeh M, Sajjadi M, Iravani S, Varma RS. Green‐synthesized nanocatalysts and nanomaterials for water treatment: current challenges and future perspectives. J Hazard Mater. 2021;401:123401. PubMed PMC
Nasrollahzadeh M, Sajjadi M, Iravani S, Varma RS. Carbon‐based sustainable nanomaterials for water treatment: state‐of‐art and future perspectives. Chemosphere. 2021;263:128005. PubMed PMC
Nasrollahzadeh M, Sajjadi M, Iravani S, Varma RS. Starch, cellulose, pectin, gum, alginate, chitin and chitosan derived (nano) materials for sustainable water treatment: a review. Carbohydr Polym. 2021;251:116986. PubMed PMC
Zhang K, Hong K, Suh JM, et al. Facile synthesis of monodispersed Pd nanocatalysts decorated on graphene oxide for reduction of nitroaromatics in aqueous solution. Res Chem Intermediat. 2019;45:599‐611.
Gadeval A, Maheshwar R, Raval N, Kalyane D, Kalia K, Tekade RK. Green graphene nanoplates for combined photo‐chemo‐thermal therapy of triple‐negative breast cancer. Nanomedicine. 2020;15(6):581‐601. PubMed
Wang H, Mi X, Li Y, Zhan S. 3D graphene‐based macrostructures for water treatment. Adv Mater. 2020;32(3):1806843. PubMed
Ali I, Alharbi OM, Tkachev A, Galunin E, Burakov A, Grachev VA. Water treatment by new‐generation graphene materials: hope for bright future. Environ Sci Pollut Res. 2018;25(8):7315‐7329. PubMed
Ahn E‐Y, Hwang SJ, Choi M‐J, Cho S, Lee H‐J, Park Y. Upcycling of jellyfish (Nemopilema nomurai) sea wastes as highly valuable reducing agents for green synthesis of gold nanoparticles and their antitumor and anti‐inflammatory activity. Artif Cells Nanomed Biotechnol. 2018;46(sup 2):1127‐1136. PubMed
Zou W, Gu B, Sun S, et al. Preparation of a graphene oxide membrane for air purification. Mater Res Express. 2019;6(10):105624.
Liang J, Cai Z, Li L, Guo L, Geng J. Scalable and facile preparation of graphene aerogel for air purification. RSC Adv. 2014;4(10):4843‐4847.
Raghav PK, Mohanty S. Are graphene and graphene‐derived products capable of preventing COVID‐19 infection. Med Hypotheses. 2020;144:110031. PubMed PMC
Ebrahimi A, Fatemi S. Titania‐reduced graphene oxide nanocomposite as a promising visible light‐active photocatalyst for continuous degradation of VVOC in air purification process. Clean Technol Environ Policy. 2017;19(8):2089‐2098.
Akhavan O, Ghaderi E. Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano. 2010;4(10):5731‐5736. PubMed
Akhavan O, Ghaderi E, Emamy H. Nontoxic concentrations of PEGylated graphene nanoribbons for selective cancer cell imaging and photothermal therapy. J Mater Chem. 2012;22(38):20626‐20633.
Li J‐L, Tang B, Yuan B, Sun L, Wang X‐G. A review of optical imaging and therapy using nanosized graphene and graphene oxide. Biomaterials. 2013;34(37):9519‐9534. PubMed
Srivastava A, Dwivedi N, Dhand C, et al. Potential of graphene‐based materials to combat COVID‐19: properties, perspectives and prospects. Mater Today Chem. 2020:100385. PubMed PMC
Kostarelos K, Novoselov KS. Graphene devices for life. Nat Nanotechnol. 2014;9(10):744‐745. PubMed
Ye S, Shao K, Li Z, et al. Antiviral activity of graphene oxide: how sharp edged structure and charge matter. ACS Appl Mater Interfaces. 2015;7(38):21571‐21579. PubMed
Priyadarsini S, Mohanty S, Mukherjee S, Basu S, Mishra M. Graphene and graphene oxide as nanomaterials for medicine and biology application. J Nanostructure Chem. 2018;8(2):123‐137.
Shafiee A, Aibaghi B, Zhang X. Determination of ethambutol in biological samples using graphene oxide based dispersive solid‐phase microextraction followed by ion mobility spectrometry. Int J Ion Mobil Spectrom. 2020;23(1):19‐27.
Muthoosamy K, Bai RG, Manickam S. Graphene and graphene oxide as a docking station for modern drug delivery system. Curr Drug Deliv. 2014;11(6):701‐718. PubMed
Daniyal M, Liu B, Wang W. Comprehensive review on graphene oxide for use in drug delivery system. Curr Med Chem. 2020;27(22):3665‐3685. PubMed
Shadjou N, Hasanzadeh M, Khalilzadeh B. Graphene based scaffolds on bone tissue engineering. Bioengineered. 2018;9(1):38‐47. PubMed PMC
Shang L, Qi Y, Lu H, et al. Graphene and graphene oxide for tissue engineering and regeneration. Theranostic Bionanomater. 2019:165‐185.
Renteria JD, Nika DL, Balandin AA. Graphene thermal properties: applications in thermal management and energy storage. Appl Sci. 2014;4(4):525‐547.
Kumar R, Sahoo S, Joanni E, et al. Heteroatom doped graphene engineering for energy storage and conversion. Mater Today. 2020;39:47‐65.
Geng P, Zheng S, Tang H, et al. Transition metal sulfides based on graphene for electrochemical energy storage. Adv Energy Mater. 2018;8(15):1703259.
Wang H, Feng H, Li J. Graphene and graphene‐like layered transition metal dichalcogenides in energy conversion and storage. Small. 2014;10(11):2165‐2181. PubMed
Liang M, Luo B, Zhi L. Application of graphene and graphene‐based materials in clean energy‐related devices. Int J Energy Res. 2009;33(13):1161‐1170.
Zhu J, Yang D, Yin Z, Yan Q, Zhang H. Graphene and graphene‐based materials for energy storage applications. Small. 2014;10(17):3480‐3498. PubMed
Caldas H, Ramos RO. Magnetization of planar four‐fermion systems. Phys Rev B. 2009;80(11):115428.
Staudenmaier L. Verfahren zur darstellung der graphitsäure. Berichte der deutschen chemischen Gesellschaft. 1898;31(2):1481‐1487.
Hoffmann U, Koenig E. Untersuchungen über Graphitoxid. Z Anorg Allg Chem. 1937;234:311‐336.
Brodie BC. On the atomic weight of graphite. Philos Trans R Soc Lond. 1859(149):249‐259.
William S, Hummers J, Offeman RE. Preparation of graphitic oxide. J Am Chem Soc. 1958;80(6):1339‐1339.
Chen J, Yao B, Li C, Shi G. An improved Hummers method for eco‐friendly synthesis of graphene oxide. Carbon. 2013;64:225‐229.
Shamaila S, Sajjad AKL, Iqbal A. Modifications in development of graphene oxide synthetic routes. Chem Eng J. 2016;294:458‐477.
Yu W, Sisi L, Haiyan Y, Jie L. Progress in the functional modification of graphene/graphene oxide: a review. RSC Adv. 2020;10(26):15328‐15345. PubMed PMC
Akhavan O, Ghaderi E, Akhavan A. Size‐dependent genotoxicity of graphene nanoplatelets in human stem cells. Biomaterials. 2012;33(32):8017‐8025. PubMed
Paredes J, Villar‐Rodil S, Fernández‐Merino M, Guardia L, Martínez‐Alonso A, Tascón J. Environmentally friendly approaches toward the mass production of processable graphene from graphite oxide. J Mater Chem. 2011;21(2):298‐306.
Kim K, Zhao Y, Jang H, et al. Large‐scale pattern growth of graphene films for stretchable transparent electrodes. Nature. 2009;457(7230):706‐710. PubMed
Somanathan T, Prasad K, Ostrikov KK, Saravanan A, Krishna VM. Graphene oxide synthesis from agro waste. Nanomaterials. 2015;5(2):826‐834. PubMed PMC
Sekhon SS, Kaur P, Kim Y‐H, Sekhon SS. 2D graphene oxide–aptamer conjugate materials for cancer diagnosis. NPJ 2D Mater Appl . 2021;5:21. 1–19.
Deng X, Liang H, Yang W, Shao Z. Polarization and function of tumor‐associated macrophages mediate graphene oxide‐induced photothermal cancer therapy. J Photochem Photobiol B. 2020;208:111913. PubMed
Jun SW, Manivasagan P, Kwon J, et al. Folic acid–conjugated chitosan‐functionalized graphene oxide for highly efficient photoacoustic imaging‐guided tumor‐targeted photothermal therapy. Int J Biol. 2020;155:961‐971. PubMed
De D, Kanta Das C, Mandal D, et al. Curcumin complexed with graphene derivative for breast cancer therapy. ACS Appl Bio Mater. 2020;3(9):6284‐6296. PubMed
Khorrami S, Abdollahi Z, Eshaghi G, Khosravi A, Bidram E, Zarrabi A. An improved method for fabrication of Ag‐GO nanocomposite with controlled anti‐cancer and anti‐bacterial behavior. A comparative study. Sci Rep. 2019;9(1):9167. PubMed PMC
Hou C, Quan H, Duan Y, Zhang Q, Wang H, Li Y. Facile synthesis of water‐dispersible Cu2O nanocrystal–reduced graphene oxide hybrid as a promising cancer therapeutic agent. Nanoscale. 2013;5(3):1227‐1232. PubMed
Tian J, Luo Y, Huang L, Feng Y, Ju H, Yu B‐Y. Pegylated folate and peptide‐decorated graphene oxide nanovehicle for in vivo targeted delivery of anticancer drugs and therapeutic self‐monitoring. Biosens Bioelectron. 2016;80:519‐524. PubMed
Liu P, Xie X, Liu M, Hu S, Ding J, Zhou W. A smart MnO2‐doped graphene oxide nanosheet for enhanced chemo‐photodynamic combinatorial therapy via simultaneous oxygenation and glutathione depletion. Acta Pharm Sin. 2021;11(3):823‐834. PubMed PMC
Zhuang W, He L, Wang K, et al. Combined adsorption and covalent linking of paclitaxel on functionalized nano‐graphene oxide for inhibiting cancer cells. ACS Omega. 2018;3(2):2396‐2405. PubMed PMC
Lin M, Shan S, Liu P, et al. Hydroxyl‐functional groups on graphene trigger the targeted delivery of antitumor drugs. J Biomed Nanotech. 2018;14(8):1420‐1429. PubMed
Ashjaran M, Babazadeh M, Akbarzadeh A, Davaran S, Salehi R. Stimuli‐responsive polyvinylpyrrolidone‐NIPPAm‐lysine graphene oxide nano‐hybrid as an anticancer drug delivery on MCF7 cell line. Artif Cells Nanomed Biotechnol. 2019;47(1):443‐454. PubMed
Singh G, Nenavathu BP, Imtiyaz K, Rizvi MMA. Fabrication of chlorambucil loaded graphene‐oxide nanocarrier and its application for improved antitumor activity. Biomed Pharmacother. 2020;129:110443. PubMed
Imani R, Shao W, Taherkhani S, Emami SH, Prakash S, Faghihi S. Dual‐functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells. Colloids Surf B. 2016;147:315‐325. PubMed
Sun Q, Wang X, Cui C, Li J, Wang Y. Doxorubicin and anti‐VEGF siRNA co‐delivery via nano‐graphene oxide for enhanced cancer therapy in vitro and in vivo. Int J Nanomed. 2018;13:3713–3728. PubMed PMC
Xu X, Wang J, Wang Y, Zhao L, Li Y, Liu C. Formation of graphene oxide‐hybridized nanogels for combinative anticancer therapy. Nanomed Nanotechnol Biol Med. 2018;14(7):2387‐2395. PubMed
Li Q, Wen J, Liu C, et al. Graphene‐nanoparticle‐based self‐healing hydrogel in preventing postoperative recurrence of breast cancer. ACS Biomater Sci Eng. 2019;5(2):768‐779. PubMed
Shirvalilou S, Khoei S, Khoee S, et al. Enhancement radiation‐induced apoptosis in C6 glioma tumor‐bearing rats via pH‐responsive magnetic graphene oxide nanocarrier. J Photochem Photobiol B. 2020;205:111827. PubMed
Qi Z, Shi J, Zhu B, Li J, Cao S. Gold nanorods/graphene oxide nanosheets immobilized by polydopamine for efficient remotely triggered drug delivery. J Mater Sci. 2020:1‐14.
Lv Y, Tao L, Bligh SA, Yang H, Pan Q, Zhu L. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide. Mater Sci Eng C. 2016;59:652‐660. PubMed
Ma N, Zhang B, Liu J, Zhang P, Li Z, Luan Y. Green fabricated reduced graphene oxide: evaluation of its application as nano‐carrier for pH‐sensitive drug delivery. Int J Pharm. 2015;496(2):984‐992. PubMed
Boran G, Tavakoli S, Dierking I, Kamali AR, Ege D. Synergistic effect of graphene oxide and zoledronic acid for osteoporosis and cancer treatment. Sci Rep. 2020;10(1):7827. PubMed PMC
Wang P, Wang X, Tang Q, et al. Functionalized graphene oxide against U251 glioma cells and its molecular mechanism. Mater Sci Eng C. 2020;116:111187. PubMed
Ghamkhari A, Abbaspour‐Ravasjani S, Talebi M, Hamishehkar H, Hamblin MR. Development of a graphene oxide‐poly lactide nanocomposite as a smart drug delivery system. Int J Biol Macromol. 2021;169:521‐531. PubMed
Pei X, Zhu Z, Gan Z, et al. PEGylated nano‐graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity. Sci Rep. 2020;10(1):2717. PubMed PMC
Ardakani TS, Meidanchi A, Shokri A, Shakeri‐Zadeh A. Fe3O4@Au/reduced graphene oxide nanostructures: combinatorial effects of radiotherapy and photothermal therapy on oral squamous carcinoma KB cell line. Ceram Int. 2020;46:28676‐28685.
Liang W, Huang Y, Lu D, et al. β‐Cyclodextrin‐hyaluronic acid polymer functionalized magnetic graphene oxide nanocomposites for targeted photo‐chemotherapy of tumor cells. Polymers. 2019;11(1):133. PubMed PMC
Du P, Yan J, Long S, et al. Tumor microenvironment and NIR laser dual‐responsive release of berberine 9‐O‐pyrazole alkyl derivative loaded in graphene oxide nanosheets for chemo‐photothermal synergetic cancer therapy. J Mater Chem B. 2020;8(18):4046‐4055. PubMed
Huang X, Chen J, Wu W, et al. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo‐photodynamic therapy triggers cell death in osteosarcoma. Acta Biomater. 2020;109:229‐243. PubMed
Sharma H, Mondal S. Functionalized graphene oxide for chemotherapeutic drug delivery and cancer treatment: a promising material in nanomedicine. Int J Mol Sci. 2020;21(17):6280. PubMed PMC
Vinothini K, Rajendran NK, Rajan M, Ramu A, Marraiki N, Elgorban AM. A magnetic nanoparticle functionalized reduced graphene oxide‐based drug carrier system for a chemo‐photodynamic cancer therapy. New J Chem. 2020;44(14):5265‐5277.
Lalwani G, D'Agati M, Khan AM, Sitharaman B. Toxicology of graphene‐based nanomaterials. Adv Drug Deliv Rev. 2016;105:109‐144. PubMed PMC
Qu Y, He F, Yu C, et al. Advances on graphene‐based nanomaterials for biomedical applications. Mater Sci Eng C. 2018;90:764‐780. PubMed
Bi Z, Li L, Yang J, et al. Graphene promotes lung cancer metastasis through Wnt signaling activation induced by DAMPs. Nanotoday. 2021;39:101175.
Shahabi M, Raissi H. Payload delivery of anticancer drug Tegafur with the assistance of graphene oxide nanosheet during biomembrane penetration: molecular dynamics simulation survey. Appl Surf Sci. 2020;517:146186.
Leitão MM, Alves CG, Melo‐Diogo DD, Lima‐Sousa R, Moreira AF, Correia IJ. Sulfobetaine methacrylate‐functionalized graphene oxide‐IR780 nanohybrids aimed at improving breast cancer phototherapy. RSC Adv. 2020;10:38621‐38630. PubMed PMC
Kumawat MK, Thakur M, Bahadur R, et al. Preparation of graphene oxide‐graphene quantum dots hybrid and its application in cancer theranostics. Mater Sci Eng C. 2019;103:109774. PubMed
Rasoulzadeh M, Namazi H. Carboxymethyl cellulose/graphene oxide bio‐nanocomposite hydrogel beads as anticancer drug carrier agent. Carbohydr Polym. 2017;168:320‐326. PubMed
Barahuie F, Saifullah B, Dorniani D, et al. Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid. Mater Sci Eng C. 2017;74:177‐185. PubMed
Guo Y, Xu H, Li Y, et al. Hyaluronic acid and Arg‐Gly‐Asp peptide modified graphene oxide with dual receptor‐targeting function for cancer therapy. J Biomater Appl. 2017;32(1):54‐65. PubMed
Huang Y‐S, Lu Y‐J, Chen J‐P. Magnetic graphene oxide as a carrier for targeted delivery of chemotherapy drugs in cancer therapy. J Magn Magn Mater. 2017;427:34‐40.
Karki N, Tiwari H, Pal M, et al. Functionalized graphene oxides for drug loading, release and delivery of poorly water soluble anticancer drug: a comparative study. Colloids Surf B. 2018;169:265‐272. PubMed
Ma K, Fu D, Liu Y, et al. Cancer cell targeting, controlled drug release and intracellular fate of biomimetic membrane‐encapsulated drug‐loaded nano‐graphene oxide nanohybrids. J Mater Chem B. 2018;6(31):5080‐5090. PubMed PMC
Abbasian M, Roudi M‐M, Mahmoodzadeh F, Eskandani M, Jaymand M. Chitosan‐grafted‐poly (methacrylic acid)/graphene oxide nanocomposite as a pH‐responsive de novo cancer chemotherapy nanosystem. Int J Biol Macromol. 2018;118:1871‐1879. PubMed
Liu B, Che C, Liu J, et al. Fabrication and antitumor mechanism of a nanoparticle drug delivery system: graphene oxide/chitosan oligosaccharide/γ‐polyglutamic acid composites for anticancer drug delivery. ChemistrySelect. 2019;4(43):12491‐12502.
Luo Y, Tang Y, Liu T, et al. Engineering graphene oxide with ultrasmall SPIONs and smart drug release for cancer theranostics. ChemComm. 2019;55(13):1963‐1966. PubMed
Jaleel JA, Ashraf SM, Rathinasamy K, Pramod K. Carbon dot festooned and surface passivated graphene‐reinforced chitosan construct for tumor‐targeted delivery of TNF‐α gene. Int J Biol Macromol. 2019;127:628‐636. PubMed
Yin Y, Nguyen TL, Wang B, et al. Simultaneous delivery of DNA vaccine and hydrophobic adjuvant using reducible polyethylenimine‐functionalized graphene oxide for activation of dendritic cells. J Ind Eng Chem. 2019;80:870‐876.
Ma N, Song A, Li Z, Luan Y. Redox‐sensitive prodrug molecules meet graphene oxide: an efficient graphene oxide‐based nanovehicle toward cancer therapy. ACS Biomater Sci Eng. 2019;5(3):1384‐1391. PubMed
Sang R, Chen M, Yang Y, et al. HAp@ GO drug delivery vehicle with dual‐stimuli‐triggered drug release property and efficient synergistic therapy function against cancer. J Biomed Mater Res A. 2019;107(10):2296‐2309. PubMed
Ayazi H, Akhavan O, Raoufi M, Varshochian R, Motlagh NSH, Atyabi F. Graphene aerogel nanoparticles for in‐situ loading/pH sensitive releasing anticancer drugs. Colloids Surf B. 2020;186:110712. PubMed
Liu K, Wang Y, Li H, Duan Y. A facile one‐pot synthesis of starch functionalized graphene as nano‐carrier for pH sensitive and starch‐mediated drug delivery. Colloids Surf B. 2015;128:86‐93. PubMed
Yaragalla S, Rajendran R, Jose J, AlMaadeed MA, Kalarikkal N, Thomas S. Preparation and characterization of green graphene using grape seed extract for bioapplications. Mater Sci Eng C. 2016;65:345‐353. PubMed
Li R, Wang Y, Du J, et al. Graphene oxide loaded with tumor‐targeted peptide and anti‐cancer drugs for cancer target therapy. Sci Rep. 2021;11:1725. PubMed PMC
Kesavan S, Meena KS, Sharmili SA, et al. Ulvan loaded graphene oxide nanoparticle fabricated with chitosan and d‐mannose for targeted anticancer drug delivery. J Drug Deliv Sci Technol. 2021;65:102760.
Dhanavel S, Revathy TA, Sivaranjani T, et al. 5‐Fluorouracil and curcumin co‐encapsulated chitosan/reduced graphene oxide nanocomposites against human colon cancer cell lines. Polym Bull. 2020;77:213‐233.
Gnanasekar S, Balakrishnan D, Seetharaman P, Arivalagan P, Chandrasekaran R, Sivaperumal S. Chrysin‐Anchored silver and gold nanoparticle‐reduced graphene oxide composites for breast cancer therapy. ACS Appl Nano Mater. 2020;3:4574‐4585.
Lee XJ, Lim HN, Gowthaman NSK, Abdul Rahman MB, Che Abdullah CA, Muthoosamy K. In‐situ surface functionalization of superparamagnetic reduced graphene oxide‐ Fe3O4 nanocomposite via Ganoderma lucidum extract for targeted cancer therapy application. Appl Surf Sci. 2020;512:145738.
Piperigkou Z, Karamanou K, Engin AB, et al. Emerging aspects of nanotoxicology in health and disease: from agriculture and food sector to cancer therapeutics. Food Chem Toxicol. 2016;91:42‐57. PubMed
Lam P‐L, Wong W‐Y, Bian Z, Chui C‐H, Gambari R. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern. Nanomedicine. 2017;12(4):357‐385. PubMed
Shi J, Kantoff P, Wooster R, Farokhzad O. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2016;17(1):20‐37. PubMed PMC
Jahanshahi M, Kowsari E, Haddadi‐Asl V, et al. An innovative and eco‐friendly modality for synthesis of highly fluorinated graphene by an acidic ionic liquid: making of an efficacious vehicle for anti‐cancer drug delivery. Appl Surf Sci. 2020:146071.
Ganesan K, Jothi VK, Natarajan A, Rajaram A, Ravichandran S, Ramalingam S. Green synthesis of copper oxide nanoparticles decorated with graphene oxide for anticancer activity and catalytic applications. Arab J Chem. 2020;13:6802‐6814.
Banerji U, Workman P. Critical parameters in targeted drug development: the pharmacological audit trail. Semin Oncol. 2016;43(4):436‐445. PubMed
Tan DSW, Thomas GV, Garrett MD, et al. Biomarker‐driven early clinical trials in oncology: a paradigm shift in drug development. Cancer J. 2009;15(5):406‐420. PubMed
Yap TA, Sandhu SK, Workman P, Bono JSd. Envisioning the future of early anticancer drug development. Nat Rev Cancer. 2010;10(7):514‐523. PubMed
Chen F, Gao W, Qiu X, et al. Graphene quantum dots in biomedical applications: recent advances and future challenges. Front Lab Med. 2017;1:192‐199.
Hare JI, Lammers T, Ashford MB, Puri S, Storm G, Barry ST. Challenges and strategies in anti‐cancer nanomedicine development: an industry perspective. Adv Drug Deliv Rev. 2017;108:25‐38. PubMed
Liu L, Ma Q, Cao J, et al. Recent progress of graphene oxide‐based multifunctional nanomaterials for cancer treatment. Cancer Nano. 2021;12:1‐31.
Durán M, Durán N, Fávaro WJ. In vivo nanotoxicological profile of graphene oxide. J Phys Conf Ser. 2017;838:012026.
Kiew SF, Kiew LV, Lee HB, Imae T, Chung LY. Assessing biocompatibility of graphene oxide‐based nanocarriers: a review. J Control Release. 2016;226:217‐228. PubMed
Zhi X, Fang H, Bao C, et al. The immunotoxicity of graphene oxides and the effect of PVP‐coating. Biomaterials. 2013;34(21):5254‐5261. PubMed
Yue H, Wei W, Yue Z, et al. The role of the lateral dimension of graphene oxide in the regulation of cellular responses. Biomaterials. 2012;33(16):4013‐4021. PubMed
Ou L, Song B, Liang H, et al. Toxicity of graphene‐family nanoparticles: a general review of the origins and mechanisms. Part Fibre Toxicol. 2016;13(1):57. PubMed PMC
Advanced MXene-Based Micro- and Nanosystems for Targeted Drug Delivery in Cancer Therapy
MXene-Based Photocatalysts in Degradation of Organic and Pharmaceutical Pollutants